Tuszynski G P, Nicosia R F
Department of Surgery, Medical College of Pennsylvania, Philadelphia, USA.
Bioessays. 1996 Jan;18(1):71-6. doi: 10.1002/bies.950180113.
Thrombospondin (TSP-1) is a large glycoprotein secreted by platelets and synthesized by many cell types, including endothelial and tumor cells. Although controversy exists about the biological function of TSP-1, the following observations suggest that TSP-1 may potentiate tumor progression. (1) Tumor metastases in mice are promoted by TSP-1 and inhibited by anti-TSP-1 antibodies. (2) TSP-1 promotes tumor cell adhesion, migration and invasion. (3) TSP-1 promotes angiogenesis in the rat aorta model. (4) TSP-1 up-regulates the plasminogen activator system through a mechanism involving the activation of TGF-beta 1. (5) Human tumors express increased levels of the CSVTCG-specific TSP-1 receptor. (6) Tumor stroma is enriched in TSP-1. (7) Cancer patients have high blood levels of TSP-1. (8) Poor patient survival correlates with a higher expression of the CSVTCG-specific TSP-1 receptor on tumor cells. In this paper we discuss the evidence that TSP-1 promotes tumor progression and present a hypothetical scheme for its mechanism of action.
血小板反应蛋白-1(TSP-1)是一种由血小板分泌、多种细胞类型(包括内皮细胞和肿瘤细胞)合成的大型糖蛋白。尽管关于TSP-1的生物学功能存在争议,但以下观察结果表明TSP-1可能促进肿瘤进展。(1)TSP-1促进小鼠肿瘤转移,而抗TSP-1抗体则抑制肿瘤转移。(2)TSP-1促进肿瘤细胞黏附、迁移和侵袭。(3)在大鼠主动脉模型中,TSP-1促进血管生成。(4)TSP-1通过涉及激活转化生长因子-β1的机制上调纤溶酶原激活系统。(5)人类肿瘤中CSVTCG特异性TSP-1受体的表达水平升高。(6)肿瘤基质中富含TSP-1。(7)癌症患者血液中TSP-1水平较高。(8)患者生存率低与肿瘤细胞上CSVTCG特异性TSP-1受体的高表达相关。在本文中,我们讨论了TSP-1促进肿瘤进展的证据,并提出了其作用机制的假设方案。